Eosinophilic hepatitis is a rare manifestation of hypereosinophilic syndrome (HES), typically requiring exclusion of infectious, drug-induced, autoimmune and neoplastic causes. We report the case of a 54-year-old woman who developed recurrent episodes of acute cholestatic hepatitis with severe peripheral eosinophilia. Despite corticosteroid responsiveness, the patient experienced relapses and intolerance to azathioprine. Introduction of mepolizumab, an anti-IL-5 monoclonal antibody, led to sustained clinical remission, normalisation of eosinophil counts and marked histological improvement, enabling steroid discontinuation. This case underscores the importance of considering HES in the differential diagnosis of eosinophilic liver infiltration and the potential role of mepolizumab as a safe and effective steroid-sparing agent in eosinophilic hepatitis.

Eosinophilic hepatitis successfully treated with mepolizumab / Pilia, A.M., Salvati, L., Del Carria, M., Ferrara, D., Mazzoni, A., Micheli, G., Leoncini, L., Messerini, L., Marra, F., Parronchi, P.. - In: FRONTLINE GASTROENTEROLOGY. - ISSN 2041-4137. - ELETTRONICO. - 17:(2025), pp. 573-576. [10.1136/flgastro-2025-103295]

Eosinophilic hepatitis successfully treated with mepolizumab

Pilia, Antonino Marcello;Salvati, Lorenzo;Del Carria, Marco;Mazzoni, Alessio;Micheli, Giulia;Leoncini, Lorenzo;Messerini, Luca;Marra, Fabio;Parronchi, Paola
2025

Abstract

Eosinophilic hepatitis is a rare manifestation of hypereosinophilic syndrome (HES), typically requiring exclusion of infectious, drug-induced, autoimmune and neoplastic causes. We report the case of a 54-year-old woman who developed recurrent episodes of acute cholestatic hepatitis with severe peripheral eosinophilia. Despite corticosteroid responsiveness, the patient experienced relapses and intolerance to azathioprine. Introduction of mepolizumab, an anti-IL-5 monoclonal antibody, led to sustained clinical remission, normalisation of eosinophil counts and marked histological improvement, enabling steroid discontinuation. This case underscores the importance of considering HES in the differential diagnosis of eosinophilic liver infiltration and the potential role of mepolizumab as a safe and effective steroid-sparing agent in eosinophilic hepatitis.
2025
17
573
576
Goal 3: Good health and well-being
Pilia, Antonino Marcello; Salvati, Lorenzo; Del Carria, Marco; Ferrara, Domenico; Mazzoni, Alessio; Micheli, Giulia; Leoncini, Lorenzo; Messerini, Luc...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1500221
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact